Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E110128-100mg | 100mg | In stock | $94.90 | |
E110128-500mg | 500mg | In stock | $177.90 | |
E110128-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $320.90 | |
E110128-5g | 5g | In stock | $1,441.90 |
DNA topoisomerase I inhibitor. Active metabolite of CPT-11.
Synonyms | UNII-0H43101T0J | BCP9000200 | 0H43101T0J | BP-24513 | CAMPTOTHECIN, 7-ETHYL-10-HYDROXY- | SN 38 lactone | AC-1357 | NCGC00167831-05 | Q-200299 | (S)-4,11-Diethyl-4,9-di-OH-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione | GTPL6925 | 1H- |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Active metabolite of irinotecan. Inhibitor of topoisomerase I.. Gene expression analysis of colon cancer cell lines treated with SN-38 showed differential effects: the majority of affected genes were down-regulated (including, most strongly, genes related |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Toxic, refer to SDS for further information. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488187375 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488187375 |
IUPAC Name | (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione |
INCHI | InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1 |
InChi Key | FJHBVJOVLFPMQE-QFIPXVFZSA-N |
Canonical SMILES | CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)O |
Isomeric SMILES | CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O |
WGK Germany | 3 |
RTECS | UQ0491000 |
Alternate CAS | 86639-52-3 |
PubChem CID | 104842 |
NSC Number | 673596 |
MeSH Entry Terms | 7 Ethyl 10 hydroxycamptothecin;7-ethyl-10-hydroxycamptothecin;Camptosar;Camptothecin 11;camptothecin-11;CPT 11;CPT-11;CPT11;irinotecan;irinotecan hydrochloride;Irrinotecan;NK012 compound;SN 38;SN 38 11;SN-38;SN-38-11;SN3811 |
Molecular Weight | 392.4 |
Reaxy-Rn | 4829984 |
PubChem SID | 488187375 |
---|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
I1926046 | Certificate of Analysis | Jul 14, 2023 | E110128 |
B2317760 | Certificate of Analysis | Jan 07, 2023 | E110128 |
B2317761 | Certificate of Analysis | Jan 07, 2023 | E110128 |
B2317767 | Certificate of Analysis | Jan 07, 2023 | E110128 |
B2317778 | Certificate of Analysis | Jan 07, 2023 | E110128 |
B2317803 | Certificate of Analysis | Jan 07, 2023 | E110128 |
B2317820 | Certificate of Analysis | Jan 07, 2023 | E110128 |
B2317862 | Certificate of Analysis | Jan 07, 2023 | E110128 |
I2207459 | Certificate of Analysis | Jul 29, 2022 | E110128 |
I2207460 | Certificate of Analysis | Jul 29, 2022 | E110128 |
I2207461 | Certificate of Analysis | Jul 29, 2022 | E110128 |
I2207462 | Certificate of Analysis | Jul 29, 2022 | E110128 |
K2327037 | Certificate of Analysis | Jul 29, 2022 | E110128 |
Sensitivity | heat sensitive |
---|---|
Specific Rotation[α] | +20.0 to +30.0 deg(C=0.2, THF) |
Melt Point(°C) | 217°C |
Pictogram(s) | GHS06, GHS08 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed H341:Suspected of causing genetic defects |
Precautionary Statements | P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P281:Use personal protective equipment as required. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P318:if exposed or concerned, get medical advice. |
WGK Germany | 3 |
RTECS | UQ0491000 |
Reaxy-Rn | 4829984 |
1. Lili Cheng, Peng Zhang, Yadong Liu, Zhuoyin Liu, Junjie Tang, Langtao Xu, Jie Liu. (2023) Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway. BIOMATERIALS, 301 (122259). [PMID:37531777] [10.1016/j.biomaterials.2023.122259] |
2. Linjie Yang, Jingyi Hong, Jing Di, Yifei Guo, Meihua Han, Meifeng Liu, Xiangtao Wang. (2023) 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy. International Journal of Nanomedicine, [PMID:28553107] [10.2147/IJN.S134005] |
3. Jinjin Chen, Lulu Zhou, Chunhui Wang, Yunhao Sun, Yonglin Lu, Ruihao Li, Xiaochun Hu, Mengyao Chen, Lv Chen, Keke Chai, Tianming Yao, Shuo Shi, Chunyan Dong. (2020) A multifunctional SN38-conjugated nanosystem for defeating myelosuppression and diarrhea induced by irinotecan in esophageal cancer. Nanoscale, 12 (41): (21234-21247). [PMID:33063070] [10.1039/D0NR06266A] |
4. Hua Sun, Xiaotong Zhou, Baojian Wu. (2015) Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells. XENOBIOTICA, 45 (11): (945-953). [PMID:26068529] [10.3109/00498254.2015.1033502] |
1. Peter S et al.. (2016) Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I.. Nucleic Acids Res, [PMID:27587582] |
2. Winkler C et al.. (2021) SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.. Br J Cancer, 124 (5): (951-962). [PMID:33339894] |
3. Lili Cheng, Peng Zhang, Yadong Liu, Zhuoyin Liu, Junjie Tang, Langtao Xu, Jie Liu. (2023) Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway. BIOMATERIALS, 301 (122259). [PMID:37531777] [10.1016/j.biomaterials.2023.122259] |
4. Linjie Yang, Jingyi Hong, Jing Di, Yifei Guo, Meihua Han, Meifeng Liu, Xiangtao Wang. (2023) 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy. International Journal of Nanomedicine, [PMID:28553107] [10.2147/IJN.S134005] |
5. Jinjin Chen, Lulu Zhou, Chunhui Wang, Yunhao Sun, Yonglin Lu, Ruihao Li, Xiaochun Hu, Mengyao Chen, Lv Chen, Keke Chai, Tianming Yao, Shuo Shi, Chunyan Dong. (2020) A multifunctional SN38-conjugated nanosystem for defeating myelosuppression and diarrhea induced by irinotecan in esophageal cancer. Nanoscale, 12 (41): (21234-21247). [PMID:33063070] [10.1039/D0NR06266A] |
6. Hua Sun, Xiaotong Zhou, Baojian Wu. (2015) Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells. XENOBIOTICA, 45 (11): (945-953). [PMID:26068529] [10.3109/00498254.2015.1033502] |